Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase

Journal of Pharmacology and Experimental Therapeutics

Volumn 318, Issue 3, 2006, Pages 1020-1026

  Singh, Dev K ^a   Li, Li ^a   Porter, Todd D ^a  

^a University of Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; ADENYLATE KINASE; CHOLESTEROL; HEXACOSANOL; MEVALONIC ACID; OCTACOSANOL; POLICOSANOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL LYSATE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HEPATOMA CELL; INCUBATION TIME; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENYLATE KINASE; ANIMALS; ANTICHOLESTEREMIC AGENTS; BLOOD GLUCOSE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHOLESTEROL; ENZYME ACTIVATION; FATTY ALCOHOLS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33747597580     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.107144     Document Type: Article

References (32)

1. Arruzazabala ML, Carbajal D, Mas R, Molina V, Valdes S, and Laguna A (1994) Cholesterol-lowering effects of policosanol on normocholesterolemic rabbits. Biol Res 27:205-210.
2. Beg ZH, Stonik JA, and Brewer HB Jr (1985) Phosphorylation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase and modulation of its enzymic activity by calcium-activated and phospholipid-dependent protein kinase. J Biol Chem 260:1682-1687.
3. Beg ZH, Stonik JA, and Brewer HB Jr (1987a) Modulation of the enzymic activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase by multiple kinase systems involving reversible phosphorylation: a review. Metabolism 36:900-917.
4. Beg ZH, Stonik JA, and Brewer HB Jr (1987b) Phosphorylation and modulation of the enzymic activity of native and protease-cleaved purified hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase by a calcium/calmodulin-dependent protein kinase. J Biol Chem 262:13228-13240.
5. Berthold HK, Unverdorben S, Degenhardt R, Bulitta M, and Gouni-Berthold I (2006) Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia. J Am Med Assoc 295:2262-2269.
6. Brown MS and Goldstein JL (1974) Suppression of 3-hydroxy-3- methylglutaryl coenzyme A reductase activity and inhibition of growth of human fibroblasts by 7-ketocholesterol. J Biol Chem 249:7306-7314.
7. Carling D, Zammit VA, and Hardie DG (1987) A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis. FEBS Lett 223:217-222.
8. Castano G, Mas R, Fernandez L, Illnait J, Mendoza S, Gamez R, Fernandez J, and Mesa M (2005) A comparison of the effects of D-003 and policosanol (5 and 10 mg/day) in patients with type II hypercholesterolemia: a randomized, double-blinded study. Drugs Exp Clin Res 31 (Suppl):31-44.
9. Castano G, Mas R, Fernandez L, Lopez E, Gutierrez JA, Illnait J, Fernandez JC, Gamez R, and Alvarez E (2002) Assessment of the effects of D-003, a new antiplatelet and lipid-lowering compound, in healthy volunteers. A phase I clinical study. Drugs R.D. 3:337-348.
10. Clark H, Carling D, and Saggerson D (2004) Covalent activation of heart AMP-activated protein kinase in response to physiological concentrations of long-chain fatty acids. Eur J Biochem 271:2215-2224.
11. Ferrer A, Caelles C, Massot N, and Hegardt FG (1985) Activation of rat liver cytosolic 3-hydroxy-3-methylglutaryl coenzyme A reductase kinase by adenosine 5′-monophosphate. Biochem Biophys Res Commun 132:497-504.
12. Gouni-Berthold I and Berthold HK (2002) Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent. Am Heart J 143:356-365.
13. Hardie DG (2003) Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology 144:5179-5183.
14. Hardie DG and Pan DA (2002) Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem Soc Trans 30:1064-1070.
15. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP, Alessi DR, and Hardie DG (2003) Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2:28.
16. Kabir Y and Kimura S (1993) Biodistribution and metabolism of orally administered octacosanol in rats. Ann Nutr Metab 37:33-38.
17. Kabir Y and Kimura S (1995) Tissue distribution of (8-14C)-octacosanol in liver and muscle of rats after serial administration. Ann Nutr Metab 39:279-284.
18. Kahn BB, Alquier T, Carling D, and Hardie DG (2005) AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1:15-25.
19. Menendez R, Amor AM, Rodeiro I, Gonzalez RM, Gonzalez PC, Alfonso JL, and Mas R (2001a) Policosanol modulates HMG-CoA reductase activity in cultured fibroblasts. Arch Med Res 32:8-12.
20. Menendez R, Arruzazabala L, Mas R, Del Rio A, Amor AM, Gonzalez RM, Carbajal D, Fraga V, Molina V, and Illnait J (1997) Cholesterol-lowering effect of policosanol on rabbits with hypercholesterolaemia induced by a wheat starch-casein diet. Br J Nutr 77:923-932.
21. Menendez R, Mas R, Amor AM, Rodeiros I, Gonzalez RM, and Alfonso JL (2001b) Inhibition of cholesterol biosynthesis in cultured fibroblasts by D003, a mixture of very long chain saturated fatty acids. Pharmacol Res 44:299-304.
22. Menendez R, Mas R, Perez J, Gonzalez RM, and Jimenez S (2004) Oral administration of D-003, a mixture of very long chain fatty acids prevents casein-induced endogenous hypercholesterolemia in rabbits. Can J Physiol Pharmacol 82:22-29.
23. Rizzo WB, Craft DA, Dammann AL, and Phillips MW (1987) Fatty alcohol metabolism in cultured human fibroblasts. Evidence for a fatty alcohol cycle. J Biol Chem 262:17412-17419.
24. Rodriguez-Echenique C, Mesa R, Mas R, Noa M, Menendez R, Gonzalez RM, Amor AM, Fraga V, Sotolongo V, and Laguna A (1994) Effects of policosanol chronically administered in male monkeys (Macaca arctoides). Food Chem Toxicol 32:565-575.
25. Shaw RJ, Kosmatka M, Bardeesy N, Hurley RL, Witters LA, DePinho RA, and Cantley LC (2004) The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci USA 101:3329-3335.
26. Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, Depinho RA, Montminy M, and Cantley LC (2005) The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science (Wash DC) 310:1642-1646.
27. Singh H, Derwas N, and Poulos A (1987) Very long chain fatty acid beta-oxidation by rat liver mitochondria and peroxisomes. Arch Biochem Biophys 259:382-390.
28. Varady KA, Wang Y, and Jones PJ (2003) Role of policosanols in the prevention and treatment of cardiovascular disease. Nutr Rev 61:376-383.
29. Wang YW, Jones PJ, Pischel I, and Fairow C (2003) Effects of policosanols and phytosterols on lipid levels and cholesterol biosynthesis in hamsters. Lipids 38:165-170.
30. Wright CM, Zielke JC, and Whayne TF (2005) Policosanol, an aliphatic alcohol sugarcane derivative: use in patients intolerant of or inadequately responsive to statin therapy. Int J Angiol 13:173-175.
31. Zang M, Zuccollo A, Hou X, Nagata D, Walsh K, Herscovitz H, Brecher P, Ruderman NB, and Cohen RA (2004) AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. J Biol Chem 279:47898-47905.
32. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, et al. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Investig 108:1167-1174.